Globally, in 2017 35 million people were living with HIV (PLHIV) and 257 million had chronic
HBV infection (HBsAg positive). The extent of HIV‐HBsAg co‐infection is unknown. We …

Objectives At present, data are limited on the comorbidity profiles associated with aging
people with HIV in the develo** world, where most such people live. The aim of this study …

Abstract Purpose of Review With the establishment of antiretroviral treatment (ART)
programs in low-and middle-income countries, people with HIV (PWH) in Latin America and …

Objective To characterize the profile of non-AIDS-related comorbidities (NARC) in the older
HIV-1-infected population and to explore the factors associated with multiple NARC …

In biomedical, public health, and popular discourses, the 'end of AIDS'has emerged as a
predominant way to understand the future of HIV research and prevention. This approach is …

Introduction People living with HIV (PLHIV) on antiretroviral therapy (ART) experience high
rates of non‐communicable diseases (NCDs). These co‐morbidities often accumulate and …

Background The HIV-Brazil Cohort Study was established to analyze the effectiveness of
combination antiretroviral therapy (cART) and the impact of this treatment on morbidity …

Background With the widespread use of combination antiretroviral therapy (cART), life
expectancy of HIV-infected patients has significantly prolonged. An increasing number of …

Background Antiretroviral therapy (ART) prolongs lifespan and decreases mortality of HIV
infected patients. However, many patients do not achieve optimal immune reconstitution …

Background Cardiovascular disease (CVD) is a leading health threat for HIV+ patients on
antiretroviral therapy (ART); cardiometabolic comorbidities are key predictors of risk. Data …